Company Filing History:

10 out of 197

Boehringer Ingelheim Kg

Boehringer Ingelheim Gmbh

Years Active: 1987-1997

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5696124 - Xanthine derivatives with adenosine-antagonistic activity (1997-12-09),

2. 5688802 - Bornyl xanthine derivatives with adenosine-antagonistic activity (1997-11-18),

3. 5641784 - 8-substituted 1,3-dialiphaticxanthine derivatives (1997-06-24),

4. 5532368 - Xanthine derivatives with adenosine-antagonistic activity (1996-07-02),

5. 5422353 - Tetrahydropyridine derivatives (1995-06-06),

6. 5196454 - Method of treating disorders of the dopaminergic systems using (1993-03-23),

7. 5068325 - 4,5,7,8-tetrahydro-6H-thiazolo[5,4-d]azepines, their preparation and (1991-11-26),

8. 5053430 - Use of 2,7-diamino-1,2,3,4-tetrahydronaphthalenes as medicaments, new (1991-10-01),

9. 4981862 - Tetrahydrobenzothiazoles, and the preparation and use thereof (1991-01-01),

10. 4886812 - Tetrahydro-benzthiazoles, the preparation thereof and their use as (1989-12-12),

11. 4871760 - Use of 2-(N-2,6-dichlorophenyl-N-allylamino)-2-imidazoline as (1989-10-03),

12. 4843086 - Tetrahydro-benzthiazoles, the preparation thereof and their use as (1989-06-27),

13. 4731374 - Tetrahydro-benzthiazoles, the preparation thereof and their use as (1988-03-15),

14. 4645770 - Agent for treating Parkinson's disease or Parkinsonism (1987-02-24),

Title: The Innovative Journey of Gunter Schingnitz in the World of Inventions

Introduction:

Gunter Schingnitz, a brilliant inventor hailing from Bad Kreuznach, DE, has left a significant mark in the realm of innovation with his relentless commitment to pioneering technologies for a brighter future.

Latest Patents:

With a total of 14 patents to his name, Gunter Schingnitz has recently introduced groundbreaking inventions such as Xanthine derivatives with adenosine-antagonistic activity, focusing on their pharmaceutical applications. Another notable innovation includes Bornyl xanthine derivatives with adenosine-antagonistic activity, showcasing his expertise in the field of pharmaceutical compositions.

Career Highlights:

Having worked with prestigious companies like Boehringer Ingelheim KG and Dr. Karl Thomae GmbH, Gunter Schingnitz has garnered invaluable experience and expertise in the pharmaceutical industry. His contributions have not only advanced the sector but have also set a high standard for innovation in the field.

Collaborations:

Throughout his illustrious career, Gunter Schingnitz has collaborated with esteemed professionals such as Joachim Mierau and Claus S Schneider, further enhancing the depth and breadth of his innovative endeavors. These collaborations have led to the development of cutting-edge solutions that have reshaped the landscape of pharmaceutical inventions.

Conclusion:

In conclusion, Gunter Schingnitz's innovative spirit and dedication to pushing the boundaries of technology have established him as a leading figure in the world of inventors. His remarkable contributions continue to inspire future generations and pave the way for transformative advancements in the field of pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.